Arzu Ergen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Renal Cell Carcinoma

Coronavirus Disease

Top Venues

Medical oncology (Northwood, London, England)

Emerging microbes & infections

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Merve Nur Atas, Barış Ertuğrul, Elif Sinem Iplik, Bedia Cakmakoglu, Arzu Ergen
The inhibitory effect of betulinic acid on epithelial-mesenchymal transition pathway in renal cell carcinoma. Medical oncology (Northwood, London, England) 39 (11) (2022)
Ilhan Tahrali, Nilgun Akdeniz, Vuslat Yılmaz, Umut Can Kucuksezer, Fatma Betul Oktelik, Özkan Özdemir, Esin Cetin Aktas, Yelda Ogutmen, Arzu Ergen, Neslihan Abacı, Erdem Tuzun, Mustafa Oral Öncül, Gunnur Deniz
The modulatory action of C-Vx substance on the immune system in COVID-19. Emerging microbes & infections 11 (1) (2022)
Levent Aydemir, Elif Sinem Iplik, Baris Ertugrul, Goksu Kasarci, Merve Nur Atas, Murat Ulusan, Arzu Ergen, Bedia Cakmakoglu
Levofloxacin might be safe to use for OSCC patients. Medical oncology (Northwood, London, England) 38 (8) (2021)
Gonca Candan, Resul Kahraman, Arzu Ergen
Irak-4 rs4251481 gene variant: as a risk factor on inflammatory bowel disease Turkish journal of medical sciences 49 (2) (2019)